EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cancer epigenetics in clinical practice

Veronica Davalos iD, Manel Esteller iD

CA: A Cancer Journal for Clinicians · 2023-07 · 73 (4) · 376-424

DOI: 10.3322/caac.21765 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 13.12.2022. Verfasst von Veronica Davalos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Josep Carreras Leukaemia Research Institute, Badalona, Catalonia, Spain. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasms. Die Arbeit wurde bisher 191-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer development is driven by the accumulation of alterations affecting the structure and function of the genome. Whereas genetic changes disrupt the DNA sequence, epigenetic alterations contribute to the acquisition of hallmark tumor capabilities by regulating gene expression programs that promote tumorigenesis. Shifts in DNA methylation and histone mark patterns, the two main epigenetic modifications, orchestrate tumor progression and metastasis. These cancer‐specific events have been exploited as useful tools for diagnosis, monitoring, and treatment choice to aid clinical decision making. Moreover, the reversibility of epigenetic modifications, in contrast to the irreversibility of genetic changes, has made the epigenetic machinery an attractive target for drug development. This review summarizes the most advanced applications of epigenetic biomarkers and epigenetic drugs in the clinical setting, highlighting commercially available DNA methylation‐based assays and epigenetic drugs already approved by the US Food and Drug Administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticNeoplasmsHumansDNA MethylationCell Transformation, Neoplastic

Stichwörter der Autor:innen

DNA methylationcancerepigenetic biomarkersepigenetic drugsepigenetics

Autor:innen und Institutionen

  • Josep Carreras Leukaemia Research Institute, Badalona, Catalonia, Spain.
  • Centro de Investigacion Biomedica en Red Cancer, Madrid, Spain.
  • Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain.
  • Institucio Catalana de Recerca i Estudis Avancats, Barcelona, Catalonia, Spain.

ORCID-Profile: Veronica Davalos, Manel Esteller

Zitieren

APA

Davalos, V., & Esteller, M. (2023). Cancer epigenetics in clinical practice. CA: A Cancer Journal for Clinicians, 73(4), 376-424. https://doi.org/10.3322/caac.21765

Vancouver

Davalos V, Esteller M. Cancer epigenetics in clinical practice. CA: A Cancer Journal for Clinicians. 2023;73(4):376-424. doi:10.3322/caac.21765

BibTeX
@article{Davalos2023,
  author = {Davalos, Veronica and Esteller, Manel},
  title = {Cancer epigenetics in clinical practice},
  journal = {CA: A Cancer Journal for Clinicians},
  year = {2023},
  volume = {73},
  number = {4},
  pages = {376--424},
  doi = {10.3322/caac.21765}
}
Kostenlos starten →